Location: Home
  • search
  • go
  • Relate News
  • 5/4/2021China Tightens Grip on Pharma Industry as It Initiates the 5th Round o...
  • 4/30/2021CROs dMed and Clinipace Merge to Accelerate Customer Success
  • 4/30/2021Sirnaomics Enters Partnership with Walvax to Co-Develop Its Antiviral ...
  • 4/30/2021CDE Solicits Comments on the Technical Guidelines for Pharmaceutical S...
  • 4/30/2021CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...
  • 4/30/2021Financial-related Company News in Brief
  • 4/30/2021Recent Official and Executive Moves
  • 4/29/2021LG Chem Signs Strategic Partnership Contract with China's TransThera o...
  • 4/29/2021Sanofi Reports China Sales Growth amid Dupixent's Launch in the Countr...
  • 4/29/2021Tianyao Fined CNY 44M for Antimonopoly Violations
  • 4/29/2021Top 20 Listed Chinese Pharmaceutical Companies by R&D Spending 2020
  • 4/29/2021PhIIC: Performance Review of Drug Products Included in the NRDL throug...
  • 4/28/2021Shanghai Launches Customized BMI Supplemental Health Insurance as the ...
  • 4/27/2021CStone's NDA of Selective Inhibitor GAVRETO(R) (Pralsetinib) Accepted ...
  • 4/27/2021I-Mab Announces Positive Topline Phase 2 Results for Olamkicept in Ulc...
  • 4/27/2021NMPA Issues the List of Reference Formulations for GQCE Studies (41st ...
  • 4/27/2021China Issues the 2021 Highlights of Correction of Irregularities in Ph...
  • 4/27/2021Annual Report of the Intellectual Property Tribunal of the Supreme Peo...
  • 4/27/2021Upcoming Event: 6th Cell & Gene Therapy Summit 2021
  • 4/27/2021Upcoming Event: 2nd International Women Health and Breast Cancer Confe...
  • 4/27/2021CANbridge Licenses LogicBio's Gene Delivery and Editing Platforms
  • 4/27/2021Vaccine Startup Clover Biopharma Files for Hong Kong IPO
  • 4/27/2021BioPlan: Chinese CDMO Sector Growing but Unlikely To Make Global Impac...
  • 4/27/2021Simcere Pharma Ditches Cell Therapy to Focus on Oncology
  • 4/26/2021SciClone Pharma Tests Hepatitis Drug as COVID-19 Vaccine Enhancer
  • 4/26/2021SMEI: Review of Chinese Terminal Drug Markets in 2011 - 2020
  • 4/23/2021Hua Medicine Files Chinese NDA for Dorzagliatin
  • 4/23/2021China and Mexico Sign Regulatory Cooperation Agreement for Medical Pro...
  • 4/23/2021Review of Out-licensing Deals of China-Originated New Drugs in 2020
  • 4/23/2021Recent Executive Moves
  • Page:203/789 Total number of articles:23668: [First][<<] [201] [202] [203] [204] [205] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group